14
Apr
2025
Finding New Targets for Cancer Drugs: Kevin Parker on The Long Run
Kevin Parker is today’s guest on The Long Run. Kevin is the co-founder and CEO of South San Francisco-based Cartography Biosciences. The company is using multi-omic tools to map out which targets are specifically expressed on cancer cells. The idea is to find new, precise targets that antibody drugs can aim for. Cartography got started during the pandemic, raised a... Read More